Recent changes in the healthcare industry can both contribute to and exacerbate clinician burnout, but can also improve the situation, said Kathleen Blake, MD, MPH, vice president for Performance Improvement at the American Medical Association.
Recent changes in the healthcare industry can both contribute to and exacerbate clinician burnout, but can also improve the situation, said Kathleen Blake, MD, MPH, vice president for Performance Improvement at the American Medical Association.
Transcript
How might recent changes in the health industry—such as value-based payment models and new technologies—exacerbate burnout?
They can exacerbate it, they can also improve it. And I think that that’s true for a lot of the transformational trends going on in healthcare today. The exacerbation, I think, we can point very clearly to the introduction of electronic health records (EHRs) systems that were designed to meet regulatory requirements, but really did not focus as much as they should have on usability, on the EHR function being imbedded into the workflow of clinicians. The second way is that, again, through regulation, there have been a lot of restrictions on how much care can be provided by other members of the care team. Members other than the physician. We’re starting to see some improvements in those areas.
And if you think about alternative payment models, alternative payment models require creativity, adaptability, data, and a commitment. When you already have limited bandwidth, in terms of time, energy, enthusiasm, it’s hard to proceed with an alternative payment model. So, what we would envision is if we can tackle some of the causes of burnout, we will see some of that natural creativity reemerge.
As Claims Denials Surge, AI and Data-Driven Insights Equip Clinicians, Hospitals to Fight Back
March 13th 2025As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in shaping the future of patient care, according to experts from Komodo Health and SmarterDx.
Read More
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More